|
|
Volumn 20, Issue 22, 1999, Pages 1603-1606
|
|
21st Congress of the European Society of Cardiology, Barcelona, Spain, 27 August to 1 September 1999: Hotline sessions
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACETYLSALICYLIC ACID;
ALPHA TOCOPHEROL;
ALTEPLASE;
AMIODARONE;
ANTICOAGULANT AGENT;
BISOPROLOL;
DILTIAZEM;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
DOBUTAMINE;
EPTIFIBATIDE;
FIBRINOGEN RECEPTOR ANTAGONIST;
LEVOSIMENDAN;
MOXONIDINE;
RAMIPRIL;
SIBRAFIBAN;
STREPTOKINASE;
TIROFIBAN;
WARFARIN;
YTTRIUM 90;
BLEEDING;
CARDIOLOGY;
CARDIOVERSION;
CLINICAL TRIAL;
CONGESTIVE HEART FAILURE;
CORONARY ARTERY BYPASS GRAFT;
CORONARY ARTERY DISEASE;
DIABETES MELLITUS;
DOSIMETRY;
DRUG FATALITY;
EDITORIAL;
HEART ATRIUM FIBRILLATION;
HEART INFARCTION;
HIGH RISK POPULATION;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
ORAL DRUG ADMINISTRATION;
OUTCOMES RESEARCH;
PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY;
PRIORITY JOURNAL;
RESTENOSIS;
STENT;
STROKE;
VASCULAR DISEASE;
CONFERENCE PAPER;
EUROPE;
MEDICAL SOCIETY;
CARDIOLOGY;
EUROPE;
HUMANS;
SOCIETIES, MEDICAL;
|
|
EID: 0033220621
PISSN: 0195668X
EISSN: None
Source Type: Journal
DOI: 10.1053/euhj.1999.1917 Document Type: Editorial |
|
Times cited : (4)
|
|
References (0)
|
